Skip to content

Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.

Randomized controlled trial · Urol J · 2021. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 32350847

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.

Sandoughdaran S, Razzaghdoust A, Tabibi A et al.
Urol J · 2021

PubMed ID
32350847
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.